Mutale Discusses Disparities in Cancer Clinical Trial Eligibility, Access and Enrollment
Dr Mutale discusses common factors contributing to decreased access to cancer clinical trials, how trial enrollment criteria can affect which groups of patients are underrepresented in these trials, and steps that researchers and clinicians can take to increase diversity in clinical trials and mitigate these disparities.
Source: onclive.com